Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Cyanohydrin. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1468212A introduces a safe, cost-effective asymmetric cyanation method using alkali metal cyanides and chiral titanium catalysts for high-purity pharmaceutical intermediates.